FundedIQ
Biotechnology

Cambridge Cognition: Funding, Investors & Team (Oct 2026)

Cambridge Cognition is a digital health company focused on neuroscience, creating products and technologies to improve brain research and assess cognitive health and wellbeing in patients all over the world.

www.cambridgecognition.com LinkedIn Bottisham, United Kingdom 51-100 employees
Total raised
$1.0M
Rounds
1
Latest
Undisclosed round
Apr 2024

Cambridge Cognition has raised $1.0M across 1 funding round on record, the most recent an undisclosed round of $1.0M announced in Apr 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Cambridge Cognition Company Profile and Key Stats

Total funding raised
$1.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$1.0M in Apr 2024
Employees
51-100
reported band
Headquarters
Bottisham, United Kingdom

Latest funding round on record: Apr 2024.

Cambridge Cognition Funding Rounds

Date
Round
Amount
Undisclosed round
$1.0M

Cambridge Cognition Founders and Leadership Team

Name
Role
Contact
John Hammond
Founder
—

No contact details are on record for this team yet.

Cambridge Cognition Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,343
$4.1M

Cambridge Cognition's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Cambridge Cognition in Biotechnology and Bottisham

Companies Similar to Cambridge Cognition

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

Cambridge Cognition Funding FAQs

What does Cambridge Cognition do?

Cambridge Cognition is a digital health company focused on neuroscience, creating products and technologies to improve brain research and assess cognitive health and wellbeing in patients all over the world.

How much funding has Cambridge Cognition raised?

Cambridge Cognition has raised $1.0M across 1 round on record. The most recent is an undisclosed round of $1.0M announced in Apr 2024.

When did Cambridge Cognition last raise funding?

Cambridge Cognition's most recent funding round on record is an undisclosed round of $1.0M, announced in Apr 2024.

Who founded Cambridge Cognition?

FundedIQ lists John Hammond (Founder) at Cambridge Cognition.

Where is Cambridge Cognition headquartered?

Cambridge Cognition is based in Bottisham, Cambridgeshire, United Kingdom.

How many employees does Cambridge Cognition have?

Cambridge Cognition is in the 51-100 employee band.

How does Cambridge Cognition's funding compare to other Biotechnology startups?

Cambridge Cognition's latest round of $1.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Cambridge Cognition Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cambridge Cognition is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.